📰 Loss Applicable News
Loss Applicable News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Loss Applicable. Real-time updates on events, politics, business and more.
January 2, 2024
Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024 CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius...
March 16, 2023
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ...
December 22, 2022
$41.7 million in cash and cash equivalents as of September 30, 2022; extends runway through December 2023 Mino-Lok® Phase 3 trial closer to completion with 169...
August 11, 2022
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing...
August 11, 2022
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing...
August 5, 2022
Management to Host Conference Call Today at 8:30 a.m. ETSANTA FE, NM / ACCESSWIRE / August 5, 2022 / Sigma Additive Solutions (NASDAQ:SASI) ("Sigma"), a leading developer of quality assurance software
May 13, 2022
/PRNewswire/ -- LogicMark, Inc. (Nasdaq: LGMK) (the "Company" or "LogicMark") (formerly Nxt-ID, Inc.), a provider of personal emergency response systems...
May 12, 2022
/PRNewswire/ -- LogicMark, Inc. (Nasdaq: LGMK) (the "Company" or "LogicMark") (formerly Nxt-ID, Inc.), a provider of personal emergency response systems...
April 26, 2022
Management to Host Conference Call Today at 4:30 p.m. ETSANTA FE, NM / ACCESSWIRE / April 26, 2022 / Sigma Labs, Inc. (NASDAQ:SGLB) (the "Company" or "Sigma Labs"), a leading developer of quality assurance
December 15, 2021
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development...